Last Updated: August 2, 2026

Extrovis Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for EXTROVIS

EXTROVIS has fourteen approved drugs.

Summary for Extrovis

US Patents:	0
Tradenames:	14
Ingredients:	12
NDAs:	14

Drugs and US Patents for Extrovis

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Extrovis	TEMOZOLOMIDE	temozolomide	CAPSULE;ORAL	205227-002	Jun 29, 2016		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Extrovis	PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE	polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride	FOR SOLUTION;ORAL	090409-001	Apr 2, 2010		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Extrovis	IFOSFAMIDE	ifosfamide	INJECTABLE;INJECTION	201689-001	Nov 26, 2012		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Extrovis	EFUDEX	fluorouracil	CREAM;TOPICAL	016831-003	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Extrovis

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Extrovis	CARAC	fluorouracil	CREAM;TOPICAL	020985-001	Oct 27, 2000	4,690,825	⤷ Start Trial
Extrovis	CARAC	fluorouracil	CREAM;TOPICAL	020985-001	Oct 27, 2000	6,670,335	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for EXTROVIS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Cream	0.5%	➤ Subscribe	2011-07-29

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Extrovis

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.